Key result
Perfusion-metabolism mismatch in ~24% of incident dialysis patients links to higher PTH, albumin, and alkaline phosphatase.
Why the study?
Little is known about the pathogenesis of cardiovascular disease in incident dialysis patients without ischemic heart disease.
Does BMIPP and myocardial perfusion imaging identify perfusion-metabolism mismatch associated with uremic cardiomyopathy in incident hemodialysis patients without ischemic heart disease?
Cross-Sectional (n=42)
Does BMIPP and myocardial perfusion imaging identify perfusion-metabolism mismatch associated with uremic cardiomyopathy in incident hemodialysis patients without ischemic heart disease?
Answers are grounded in this paper and cite their sources.
A perfusion-metabolism mismatch on SPECT imaging is present in some incident dialysis patients without ischemic heart disease and is associated with elevated PTH, suggesting the presence of uremic cardiomyopathy.
Cardiovascular disease is the leading cause of death in dialysis patients and is significantly associated with poor survival in incident dialysis patients. However, little is known about the pathogenesis of cardiovascular disease in these populations. (123) I-15-(p-iodophenyl)-3(R,S)- methylpentadecanoic acid (BMIPP) imaging is useful for detection of ischemic heart disease. We examined imaging characteristics to identify potential pathologies of cardiac disease, other than ischemic heart disease. The subjects were 42 incident dialysis patients without histories of ischemic heart disease such as acute coronary syndrome. All the patients underwent BMIPP imaging in addition to a screening examination. Patients with positive findings in BMIPP imaging underwent myocardial perfusion imaging within 2 weeks after BMIPP imaging to evaluate the possibility of ischemic heart disease. Twenty-two patients were BMIPP-positive and 10 of these patients had negative findings on perfusion imaging and were defined as mismatch cases. Compared with patients who were BMIPP- and perfusion-positive, the mismatch cases had higher parathyroid hormone (PTH), serum albumin, and alkaline phosphatase levels. The mismatch cases also formed the largest proportion in the highest PTH tertile. A histologic examination of a mismatch case with no stenotic lesions in the coronary artery revealed the presence of cardiac hypertrophy and fibrosis. These findings suggest that a perfusion-metabolism mismatch may be present in incident dialysis patients without a history of ischemic heart disease. This mismatch is associated with PTH, which suggests potential involvement of uremic cardiomyopathy in the pathology of cardiac disease in these patients.
No takes yet. Share an insight, caveat, or question.
Koyama‐Nakamura et al. (2015) conducted a cross-sectional in Incident dialysis without ischemic heart disease (n=42). Perfusion-metabolism mismatch vs. BMIPP- and perfusion-positive patients was evaluated on Parathyroid hormone (PTH), serum albumin, and alkaline phosphatase levels.
Synapse has enriched 10 related papers. Consider them for comparative context: